Zobrazeno 1 - 10
of 330
pro vyhledávání: '"P. Moroni-Zentgraf"'
Autor:
Stanley J. Szefler, Stanley Goldstein, Christian Vogelberg, George W. Bensch, John Given, Branko Jugovic, Michael Engel, Petra M. Moroni-Zentgraf, Ralf Sigmund, Eckard H. Hamelmann
Publikováno v:
Pulmonary Therapy, Vol 6, Iss 2, Pp 151-158 (2020)
Abstract Introduction In pediatric patients with asthma, measurements of forced expiratory volume in 1 s (FEV1) may be normal or may not correlate with symptom severity. Forced expiratory flow at 25–75% of the vital capacity (FEF25–75%) is a pote
Externí odkaz:
https://doaj.org/article/c1669d47183840dca03f463fcc3eb098
Autor:
David M. G. Halpin, Eckard H. Hamelmann, Peter A. Frith, Petra M. Moroni-Zentgraf, Benjamin van Hecke, Anna Unseld, Huib A. M. Kerstjens, Stanley J. Szefler
Publikováno v:
Pulmonary Therapy, Vol 6, Iss 1, Pp 131-140 (2020)
Plain Language Summary Asthma is characterised by problems with the way that the lungs work, particularly narrowing of the airways. Doctors can measure the effect of asthma on someone’s breathing in different ways. We looked to see whether these di
Externí odkaz:
https://doaj.org/article/ed22291ee22d41188e1e0bd97d0a54ec
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
David M. G. Halpin, Eli O. Meltzer, Wendelgard Pisternick-Ruf, Petra Moroni-Zentgraf, Michael Engel, Liliana Zaremba-Pechmann, Thomas Casale, J. Mark FitzGerald
Publikováno v:
Respiratory Research, Vol 20, Iss 1, Pp 1-9 (2019)
Abstract Background The primary lung function endpoint in clinical trials in adolescent and adult patients with asthma is usually forced expiratory volume in one second (FEV1). The objective of our analysis was to assess whether peak expiratory flow
Externí odkaz:
https://doaj.org/article/d1bf82ec35624f0db689b7d3979a7550
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Canadian Respiratory Journal, Vol 2018 (2018)
Externí odkaz:
https://doaj.org/article/0461e70fc13b49118a5c75013a5a6828
Autor:
John Given, Branko Jugovic, Stanley J. Szefler, Stanley Goldstein, Eckard Hamelmann, George W Bensch, Christian Vogelberg, Ralf Sigmund, Michael Engel, P. Moroni-Zentgraf
Publikováno v:
Pulmonary Therapy, Vol 6, Iss 2, Pp 151-158 (2020)
Pulmonary Therapy
Pulmonary Therapy
Introduction In pediatric patients with asthma, measurements of forced expiratory volume in 1 s (FEV1) may be normal or may not correlate with symptom severity. Forced expiratory flow at 25–75% of the vital capacity (FEF25–75%) is a potentially m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d2a380496d24d72d808e896f008b6b2
https://doi.org/10.1007/s41030-020-00117-6
https://doi.org/10.1007/s41030-020-00117-6
Autor:
Anna Unseld, Benjamin Van Hecke, Eckard Hamelmann, Peter Frith, David M.G. Halpin, Stanley J. Szefler, P. Moroni-Zentgraf, Huib A. M. Kerstjens
Publikováno v:
Pulmonary Therapy, Vol 6, Iss 1, Pp 131-140 (2020)
Pulmonary Therapy
Pulmonary Therapy, 6, 131-140. Springer
Pulmonary Therapy
Pulmonary Therapy, 6, 131-140. Springer
Introduction Airway obstruction is usually assessed by measuring forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC) and peak expiratory flow (PEF). This post hoc study investigated comparative responses of lung function measurements
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c61265c59201349b33d0de34a5fa993
https://doaj.org/article/ed22291ee22d41188e1e0bd97d0a54ec
https://doaj.org/article/ed22291ee22d41188e1e0bd97d0a54ec
Autor:
Ken Ohta, Masakazu Ichinose, Yuji Tohda, Michael Engel, Petra Moroni-Zentgraf, Satoko Kunimitsu, Wataru Sakamoto, Mitsuru Adachi
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0124109 (2015)
This study assessed the long-term safety and efficacy of tiotropium Respimat, a long-acting inhaled anticholinergic bronchodilator, in asthma, added on to inhaled corticosteroids (ICS) with or without long-acting β2-agonist (LABA).285 patients with
Externí odkaz:
https://doaj.org/article/ebf644e18b624d7f8eb45436855b1f5d
Autor:
Judy M Bradley, Paul Koker, Qiqi Deng, Petra Moroni-Zentgraf, Felix Ratjen, David E Geller, J Stuart Elborn, Tiotropium Cystic Fibrosis Study Group
Publikováno v:
PLoS ONE, Vol 9, Iss 9, p e106195 (2014)
Tiotropium is a once-daily, long-acting anticholinergic bronchodilator with the potential to alleviate airway obstruction in cystic fibrosis. Our objective was to evaluate the efficacy and safety of 2.5 and 5 µg once-daily tiotropium delivered via t
Externí odkaz:
https://doaj.org/article/5f7b830277054bceb0ad2647b8e7d344